Related Experiment Video
Updated: Apr 24, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Netilmicin-induced carpopedal spasm
Roja Y Ramani1, Benu Panigrahy2, Bandana Rath1
1Department of Pharmacology, Maharaja Krishna Chandra Gajapati Medical College and Hospital, Berhampur, Odisha, India.
Netilmicin, an antibiotic, can cause electrolyte imbalances like hypocalcemia, leading to carpopedal spasm. This highlights the need for monitoring even with newer gentamicin-family drugs.
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Aminoglycosides are common antibiotics but can cause kidney damage (nephrotoxicity).
- Netilmicin, a gentamicin-related antibiotic, is often used for resistant infections and has a lower risk of ototoxicity and nephrotoxicity.
- Despite its safety profile, netilmicin can still lead to electrolyte disturbances.
Observation:
- Two patients developed carpopedal spasm, a symptom of low calcium levels (hypocalcemia).
- This occurred after receiving netilmicin treatment.
- The hypocalcemia was attributed to the kidneys improperly retaining electrolytes (renal electrolyte wasting).
Findings:
- Netilmicin use can lead to symptomatic hypocalcemia, hypomagnesemia, and hypokalemia.
- Renal electrolyte wasting is a potential adverse effect of netilmicin.
- Carpopedal spasm is a clinical manifestation of netilmicin-induced hypocalcemia.
Implications:
- Patients treated with netilmicin should be monitored for electrolyte imbalances, particularly calcium, magnesium, and potassium.
- Early detection and management of electrolyte wasting can prevent serious complications like carpopedal spasm.
- This case series underscores the importance of vigilance for adverse effects even with antibiotics considered safer.
Related Concept Videos
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...

